NASDAQ : AMIX
Autonomix Medical, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 1.81 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.55M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 3.29M |
| Enterprise Value | -167,304 |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 1.96M |
| Shares Outstanding | 1.96M |
| Shares Change (YoY) | +316.60% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 5.44% |
| Owned by Institutions (%) | 3.02% |
| Float | 1.85M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.31 |
| P/TBV Ratio | 1.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.85 |
| Quick Ratio | 4.23 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -315.99% |
| Return on Assets (ROA) | -157.81% |
| Return on Invested Capital (ROIC) | -200.89% |
| Return on Capital Employed (ROCE) | -518.12% |
| Weighted Average Cost of Capital (WACC) | -0.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.46M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -0.94 |
| 52-Week Price Change | -92.23% |
| 50-Day Moving Average | 3.75 |
| 200-Day Moving Average | 6.74 |
| Relative Strength Index (RSI) | 18.48 |
| Average Volume (20 Days) | 53,163 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 58,986 |
| Short Previous Month | 26,830 |
| Short % of Shares Out | 3.01% |
| Short % of Float | 3.18% |
| Short Ratio (days to cover) | 0.29 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.38M |
| Pretax Income | -16.11M |
| Net Income | -16.11M |
| EBITDA | -16.37M |
| EBIT | -16.38M |
| Earnings Per Share (EPS) | -$36.37 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 3.46M |
| Total Debt | n/a |
| Net Cash | 3.46M |
| Net Cash Per Share | $1.77 |
| Equity (Book Value) | 3.16M |
| Book Value Per Share | 5.83 |
| Working Capital | 3.15M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -13.22M |
| Capital Expenditures | -10,000 |
| Depreciation & Amortization | 12,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -13.23M |
| FCF Per Share | -$6.75 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -316.60% |
| Shareholder Yield | -316.60% |
| Earnings Yield | -2,165.01% |
| FCF Yield | -373.00% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $40.80 |
| Price Target Difference | 2,328.57% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 24, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:21 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |